The combination with anti-PD-L1 treatment resulted in complete remission of the tumors in 10 of the 15 TC-1 tumor-bearing mice and improved overall survival to approximately 70% from less than 10% for anti-PD-L1 alone and 30% for the RNA-LPX vaccine alone. The gene discussed is CD274; the disease is neoplasm.